Excellent buying at these levels - trial soon to complete, anticipation of positive results, fully funded. Should be 20 to 50 per cent upside from here. the SP has always advanced considerably toward upcoming milestones in the past.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025